An inverted J-shaped association of serum uric acid with muscle strength among Japanese adult men: a cross-sectional study.

Publisher: BioMed Central Country of Publication: England NLM ID: 100968565 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2474 (Electronic) Linking ISSN: 14712474 NLM ISO Abbreviation: BMC Musculoskelet Disord Subsets: MEDLINE

Original Publication: London : BioMed Central, [2000-

Muscle Strength*; Hyperuricemia/*blood ; Muscle, Skeletal/*physiopathology ; Uric Acid/*blood; Adult ; Age Factors ; Asian People ; Biomarkers/blood ; Cross-Sectional Studies ; Hand Strength ; Humans ; Hyperuricemia/diagnosis ; Hyperuricemia/ethnology ; Hyperuricemia/physiopathology ; Japan/epidemiology ; Male ; Middle Aged ; Risk Factors ; Sex Factors

Background: Uric acid (UA) may protect muscle function from oxidative damage due to reactive oxygen species through its powerful antioxidant capacity. However, several studies have demonstrated that hyperuricemia is closely related to systemic inflammation and has oxidant properties effects, both of which may increase the risk of muscle strength loss. The purpose of this study was to examine the association of serum UA concentration with grip strength and leg extension power in adult men.
Methods: This study is a cross-sectional survey in which 630 Japanese male employees aged 30 years and older participated. Five hundred and eighty-six subjects participated in the measurement of grip strength, and 355 subjects participated in the measurement of leg extension power. Blood samples were obtained for serum UA analysis.
Results: After adjustment for potential confounders, grip strength differed significantly between participants with and those without hyperuricemia (geometric mean and 95% confidence interval [CI]: 40.3 [39.2-41.3] kg vs. 41.9 [41.3-42.5] kg; P = 0.01). In addition, serum UA levels (quartiles) showed an inverted J-shaped curve with grip strength (mean and 95% CI: Q1, 41.6 [40.6-42.6] kg; Q2, 42.2 [41.2-43.2] kg; Q3, 41.8 [40.8-42.8] kg; Q4, 40.4 [39.3-41.4] kg; P for quadratic trend = 0.05). The results in the leg extension power group were similar to those observed in the grip strength group.
Conclusion: This population-based cross-sectional study shows for the first time that hyperuricemia is associated with poor muscle strength. Moreover, the results indicate an inverted J-shaped association between serum UA quartiles and muscle strength.

J Epidemiol. 2012;22(2):151-9. (PMID: 22343326)
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):242-8. (PMID: 15031308)
J Nutr Health Aging. 2009 Mar;13(3):177-82. (PMID: 19262948)
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. (PMID: 12900694)
Proc Natl Acad Sci U S A. 1981 Nov;78(11):6858-62. (PMID: 6947260)
J Am Geriatr Soc. 2007 Aug;55(8):1206-15. (PMID: 17661959)
Am J Physiol Endocrinol Metab. 2003 Mar;284(3):E481-7. (PMID: 12419777)
BMJ. 2008 Jul 01;337:a439. (PMID: 18595904)
J Am Geriatr Soc. 2010 Dec;58(12):2363-8. (PMID: 21143443)
J Epidemiol. 2007 Sep;17(5):177. (PMID: 17827865)
Nephrol Dial Transplant. 2004 Feb;19(2):457-62. (PMID: 14736974)
Am J Med. 2007 Apr;120(4):337-42. (PMID: 17398228)
BMC Psychiatry. 2001;1:6. (PMID: 11806757)
N Engl J Med. 2008 Oct 23;359(17):1811-21. (PMID: 18946066)
Nutr Metab Cardiovasc Dis. 2014 Jan;24(1):42-9. (PMID: 23786825)
Circulation. 2009 Oct 20;120(16):1640-5. (PMID: 19805654)
J Appl Physiol (1985). 2007 Jul;103(1):17-20. (PMID: 17379753)
Nutr Metab Cardiovasc Dis. 2012 Mar;22(3):277-84. (PMID: 20880683)
Am J Med. 2006 Jun;119(6):526.e9-17. (PMID: 16750969)
PLoS One. 2011;6(5):e19901. (PMID: 21625475)
Am J Kidney Dis. 2006 Nov;48(5):761-71. (PMID: 17059995)
Brain. 2009 Feb;132(Pt 2):377-82. (PMID: 19036766)
Mech Ageing Dev. 2008 Sep;129(9):522-7. (PMID: 18534661)
Nutr Metab (Lond). 2004 Oct 19;1(1):10. (PMID: 15507132)
Seishin Shinkeigaku Zasshi. 1973 Oct;75(10):673-9. (PMID: 4798819)
Eur J Appl Physiol. 2011 Jul;111(7):1545-52. (PMID: 21188413)
Ann Intern Med. 2005 Oct 4;143(7):499-516. (PMID: 16204163)
Clin Nutr. 2005 Feb;24(1):143-50. (PMID: 15681112)
Br J Clin Pharmacol. 2004 Jun;57(6):695-713. (PMID: 15151515)
Arch Biochem Biophys. 2000 Apr 15;376(2):333-7. (PMID: 10775420)
Am J Kidney Dis. 2009 Jun;53(6):982-92. (PMID: 19339088)
Eur J Clin Invest. 1997 Jun;27(6):484-90. (PMID: 9229228)
Free Radic Biol Med. 1999 Sep;27(5-6):617-22. (PMID: 10490283)
Eur J Appl Physiol Occup Physiol. 1990;60(5):385-90. (PMID: 2369911)
Eur Heart J. 2006 May;27(10):1174-81. (PMID: 16611671)
J Gerontol A Biol Sci Med Sci. 2009 Nov;64(11):1183-9. (PMID: 19622801)
Hypertension. 2003 Jun;41(6):1183-90. (PMID: 12707287)
Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E433-7. (PMID: 12857678)
Free Radic Biol Med. 1999 Feb;26(3-4):303-8. (PMID: 9895220)
J Gerontol A Biol Sci Med Sci. 1995 Nov;50 Spec No:5-8. (PMID: 7493218)
Lancet. 2010 Jan 23;375(9711):318-28. (PMID: 19692116)

0 (Biomarkers)
268B43MJ25 (Uric Acid)

Date Created: 20130905 Date Completed: 20140709 Latest Revision: 20221207

20221213

PMC3766665

10.1186/1471-2474-14-258

24000893